Trial Watch

Clinical trials covered by The Clinical Lighthouse, ranked by methodological rigor and ordered by most recent.

192 trials indexed
Prehospital Whole Blood Does Not Reduce 30-Day Mortality Over Components
PIVOTAL TRIAL · LAST 30 DAYS
Randomized Controlled Trial New England Journal of Medicine

Prehospital Whole Blood Does Not Reduce 30-Day Mortality Over Components

A large-scale trial found no significant difference in 30-day mortality between prehospital whole blood and component transfusions for trauma…

May 20, 2026 Read the trial →
Remote Ischaemic Preconditioning Fails to Prevent Postoperative Myocardial Injury Randomized Controlled Trial
British Journal of Anaesthesia

Remote Ischaemic Preconditioning Fails to Prevent Postoperative Myocardial Injury

A randomized trial of two-session preconditioning in abdominal surgery shows no reduction in injury and a paradoxical troponin increase.

April 25, 2026
Vuzix Head-Mounted Device Scores Highest in Prehospital Stroke Triage Simulation Non-Randomized Controlled Trial
Scandinavian Journal of Trauma Resuscitation and Emergency Medicine

Vuzix Head-Mounted Device Scores Highest in Prehospital Stroke Triage Simulation

A comparative study finds neurologists prefer head-mounted video quality while paramedics favor smartphone usability for remote triage.

April 25, 2026
Ketamine Does Not Reduce 28-Day Mortality Compared With Etomidate Randomized Controlled Trial
New England Journal of Medicine

Ketamine Does Not Reduce 28-Day Mortality Compared With Etomidate

A randomized trial of 2,365 critically ill adults found no survival benefit for ketamine, despite a higher rate of cardiovascular collapse.

April 25, 2026
Focal Coronary Disease Predicts Greater Angina Relief After Stenting Randomized Controlled Trial
Journal of the American College of Cardiology

Focal Coronary Disease Predicts Greater Angina Relief After Stenting

New ORBITA-2 data show focal lesions derive significantly more placebo-controlled benefit from PCI than diffuse disease patterns.

April 24, 2026
LB-102 Reduces Acute Schizophrenia Symptoms in Phase 2 Trial Randomized Controlled Trial
JAMA Psychiatry

LB-102 Reduces Acute Schizophrenia Symptoms in Phase 2 Trial

A randomized trial of the benzamide derivative LB-102 demonstrated significant PANSS score improvements across three daily dose levels.

April 24, 2026
Nirmatrelvir-Ritonavir Fails to Reduce Hospitalization in Vaccinated Outpatients Randomized Controlled Trial
New England Journal of Medicine

Nirmatrelvir-Ritonavir Fails to Reduce Hospitalization in Vaccinated Outpatients

Two randomized trials show no significant clinical benefit for high-risk adults with prior immunity from vaccination or infection.

April 24, 2026
Early Enteral Nutrition Reduces Complication Burden After Pancreatoduodenectomy Randomized Controlled Trial
JAMA Surgery

Early Enteral Nutrition Reduces Complication Burden After Pancreatoduodenectomy

A randomized trial shows immediate tube feeding lowers the comprehensive complication index in patients at high nutritional risk.

April 24, 2026
Funnel-Shaped Mesh Reduces Parastomal Hernia Risk After Rectal Cancer Surgery Randomized Controlled Trial
JAMA Surgery

Funnel-Shaped Mesh Reduces Parastomal Hernia Risk After Rectal Cancer Surgery

A randomized trial shows prophylactic mesh lowers three-year clinical hernia rates from 39% to 10% without increasing complications.

April 24, 2026
Telepractice PTR-F Improves Parent Fidelity in Chinese American Families Non-Randomized Controlled Trial
Frontiers in Psychiatry

Telepractice PTR-F Improves Parent Fidelity in Chinese American Families

A culturally adapted behavioral intervention delivered remotely increased parent adherence and reduced challenging behaviors in autistic children.

April 24, 2026
Tucidinostat Improves Event-Free Survival in Double-Expressor B-Cell Lymphoma Randomized Controlled Trial
JAMA

Tucidinostat Improves Event-Free Survival in Double-Expressor B-Cell Lymphoma

Adding a histone deacetylase inhibitor to R-CHOP increases complete response rates and reduces progression risk in high-risk patients.

April 24, 2026
Dialectical Behavior Therapy and Schema Therapy Show Similar Efficacy for BPD Randomized Controlled Trial
JAMA Psychiatry

Dialectical Behavior Therapy and Schema Therapy Show Similar Efficacy for BPD

A 3-year randomized trial found no significant difference in symptom reduction or dropout between these two intensive psychotherapies.

April 24, 2026
Tranexamic Acid Reduces Major Bleeding in Urologic Surgery Randomized Controlled Trial
European Urology

Tranexamic Acid Reduces Major Bleeding in Urologic Surgery

A randomized trial of 1,124 patients shows TXA reduces major bleeding by 3.4% without significantly increasing 30-day thrombotic risk.

April 23, 2026
Behavioral Nursing Model Improves Glycemic Control and Cognition in Older Diabetes Patients Randomized Controlled Trial
Frontiers in Psychiatry

Behavioral Nursing Model Improves Glycemic Control and Cognition in Older Diabetes Patients

A three-month Information-Motivation-Behavioral Skills intervention reduced HbA1c and psychological distress while improving cognitive scores.

April 23, 2026
Estradiol Patches Noninferior to LHRH Agonists in Prostate Cancer Randomized Controlled Trial
New England Journal of Medicine

Estradiol Patches Noninferior to LHRH Agonists in Prostate Cancer

A phase 3 trial shows transdermal estradiol maintains metastasis-free survival while reducing hot flashes in locally advanced disease.

April 23, 2026
Participation-Focused Training Improves Immediate Post-Stroke Executive Function in Randomized Trial Randomized Controlled Trial
Annals of Physical and Rehabilitation Medicine

Participation-Focused Training Improves Immediate Post-Stroke Executive Function in Randomized Trial

Strategy training shows short-term cognitive gains in stroke survivors, though benefits do not persist at three-month follow-up.

April 23, 2026
Immune-Guided Strategy Reduces CMV Disease in Kidney Transplant Recipients Non-Randomized Controlled Trial
Transplantation

Immune-Guided Strategy Reduces CMV Disease in Kidney Transplant Recipients

Early assessment of cell-mediated immunity allows for targeted prophylaxis, lowering symptomatic disease rates in seropositive patients.

April 23, 2026
Improved House Design Reduces Malaria and Respiratory Infections in Children Randomized Controlled Trial
Nature Medicine

Improved House Design Reduces Malaria and Respiratory Infections in Children

A cluster-randomized trial in rural Africa shows that Star Homes lower malaria incidence by 44% and improve linear growth in children.

April 23, 2026
Immersive Virtual Reality Improves Naming in Chronic Non-Fluent Aphasia Randomized Controlled Trial
Clinical Rehabilitation

Immersive Virtual Reality Improves Naming in Chronic Non-Fluent Aphasia

A randomized trial shows immersive therapy yields higher gains in oral motor function and patient enjoyment than conventional methods.

April 22, 2026
Memantine Reduces Premature Atrial Contractions and New-Onset Atrial Fibrillation Randomized Controlled Trial
Circulation

Memantine Reduces Premature Atrial Contractions and New-Onset Atrial Fibrillation

A phase 2 trial shows targeting cardiac N-methyl-D-aspartate receptors significantly lowers atrial ectopy and tachyarrhythmia burden.

April 22, 2026
Adding Tobramycin to Vancomycin Powder Does Not Reduce Tibial Fracture Infections Randomized Controlled Trial
JAMA

Adding Tobramycin to Vancomycin Powder Does Not Reduce Tibial Fracture Infections

A randomized trial of 1528 patients shows dual intrawound antibiotic powder offers no benefit over vancomycin alone in high-risk fractures.

April 22, 2026
Eccentric Cycling Matches Concentric Training for Post-COVID-19 Walking Recovery Randomized Controlled Trial
Annals of Physical and Rehabilitation Medicine

Eccentric Cycling Matches Concentric Training for Post-COVID-19 Walking Recovery

An 8-week trial shows eccentric cycling is safe and improves walking distance, though it offers no advantage over concentric exercise.

April 22, 2026
Mosunetuzumab and Polatuzumab Vedotin Show High Response in Refractory MCL Non-Randomized Controlled Trial
Blood Journal

Mosunetuzumab and Polatuzumab Vedotin Show High Response in Refractory MCL

A phase 2 trial reports a 78.6% complete response rate in patients with mantle cell lymphoma after Bruton tyrosine kinase inhibitor failure.

April 22, 2026
Baseline Connectivity Predicts Anxiety Improvement in Prefrontal TMS Trial Randomized Controlled Trial
Neuropsychopharmacology

Baseline Connectivity Predicts Anxiety Improvement in Prefrontal TMS Trial

Pre-treatment neural architecture, rather than post-stimulation connectivity changes, correlates with clinical recovery in patients.

April 22, 2026
Seven-Day Low-Plastic Intervention Lowers Urinary Phthalates and Bisphenol A Randomized Controlled Trial
Nature Medicine

Seven-Day Low-Plastic Intervention Lowers Urinary Phthalates and Bisphenol A

A randomized trial shows that minimizing plastic contact in food and personal care reduces endocrine disruptors linked to metabolic risk.

April 22, 2026
Thrombectomy Increases Tissue Salvage in Distal Vessel Occlusion Stroke Randomized Controlled Trial
JAMA Neurology

Thrombectomy Increases Tissue Salvage in Distal Vessel Occlusion Stroke

A post hoc analysis of the DISTAL trial shows endovascular therapy preserves more at-risk brain tissue than medical management alone.

April 21, 2026
Cibisatamab and FAP-4-1BBL Show Activity in Refractory Colorectal Cancer Non-Randomized Controlled Trial
Nature Medicine

Cibisatamab and FAP-4-1BBL Show Activity in Refractory Colorectal Cancer

A phase 1b trial finds that combining a CEA-targeted bispecific antibody with localized 4-1BB co-stimulation induces objective responses.

April 21, 2026
Telehealth Integration Does Not Prevent Quality of Life Decline in Palliative Care Randomized Controlled Trial
Journal of Palliative Medicine

Telehealth Integration Does Not Prevent Quality of Life Decline in Palliative Care

A randomized trial of 182 patients found no significant differences in symptom burden or security between telehealth and standard care.

April 21, 2026
Large Language Models Reduce Radiology Reporting Time and Transcription Errors Non-Randomized Controlled Trial
European Radiology

Large Language Models Reduce Radiology Reporting Time and Transcription Errors

A multicenter study finds LLMs faster than conventional speech recognition but notes inconsistent efficiency and new error types.

April 21, 2026
Cilta-cel Induces Universal MRD Negativity in High-Risk Smoldering Multiple Myeloma Non-Randomized Controlled Trial
Nature Medicine

Cilta-cel Induces Universal MRD Negativity in High-Risk Smoldering Multiple Myeloma

A phase 2 trial shows 100% of patients achieved deep, sustained responses without prior induction therapy or disease progression.

April 21, 2026
Cerebral Oximetry Fails to Improve 2-Year Outcomes in Preterm Infants Randomized Controlled Trial
JAMA Pediatrics

Cerebral Oximetry Fails to Improve 2-Year Outcomes in Preterm Infants

A phase 3 trial of 1,601 infants shows no reduction in death or disability when using oximetry to guide early postnatal care.

April 21, 2026